Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process

References

• American Society of Health-System Pharmacists. 2016. AHFS Drug Information 2016. Maryland USA: American Society of Health-System Pharmacists.
   Google Scholar
• Al-Qadi S, Grenha A, Remuñán-López C. 2011. Microspheres loaded with polysaccharide nanoparticles for pulmonary delivery: preparation, structure and surface analysis. Carbohydr Polym. 86:25–34.
   Web of Science ®Google Scholar
• Andrade F, Rafael D, Videira M, Ferreira D, Sosnik A, Sarmento B. 2013. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv Drug Del Rev. 65:1816–1827.
   PubMed Web of Science ®Google Scholar
• Benet LZ, Broccatelli F, Oprea TI. 2011. BDDCS applied to over 900 drugs. Am Assoc Pharm Scips J. 13:519–547.
   Google Scholar
• Bosso JA. 1989. Use of ciprofloxacin in cystic fibrosis patients. Am J Med. 87:S123–S127.
   PubMed Web of Science ®Google Scholar
• Cabral-Marques H, Almeida R. 2009. Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes. Eur J Pharm Biopharm. 73:121–129.
   PubMed Web of Science ®Google Scholar
• Chew NYK, Chan H‐K. 2001. Use of solid corrugated particles to enhance powder aerosol performance. Pharm Res. 18:1570–1577.
   PubMed Web of Science ®Google Scholar
• Chono S, Suzuki H, Togami K, Morimoto K. 2011. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections. Drug Dev Ind Pharm. 37:367–372.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. 2007. Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections. Drug Metab Pharmacokinet. 22:88–95.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. 2008a. Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects. Drug Dev Ind Pharm. 34:1090–1096.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. 2008b. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J Control Release. 127:50–58.
   PubMed Web of Science ®Google Scholar
• Chougule M, Padhi B, Misra A. 2007. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. Int J Nanomed. 2:675
   PubMed Web of Science ®Google Scholar
• Chougule M, Padhi B, Misra A. 2008. Development of spray dried liposomal dry powder inhaler of dapsone. AAPS PharmSciTech. 9:47–53.
   PubMed Web of Science ®Google Scholar
• CLSI. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard—Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
   Google Scholar
• Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. 2006. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm. 314:72–82.
   PubMed Web of Science ®Google Scholar
• Ezzati Nazhad Dolatabadi J, Hamishehkar H, Valizadeh H. 2015. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Drug Dev Ind Pharm. 41:1431–1437.
   PubMed Web of Science ®Google Scholar
• Faghihi H, Vatanara A, Najafabadi AR, Ramezani V, Gilani K. 2014. The use of amino acids to prepare physically and conformationally stable spray-dried IgG with enhanced aerosol performance. Int J Pharm. 466:163–171.
   PubMed Web of Science ®Google Scholar
• Farhangi M, Kobarfard F, Mahboubi A, Vatanara A, Mortazavi SA. 2018. Preparation of an optimized ciprofloxacin-loaded chitosan nanomicelle with enhanced antibacterial activity. Drug Dev Ind Pharm. 44:1273–1284.
   PubMed Web of Science ®Google Scholar
• Gaspar DP, Serra C, Lino PR, Gonçalves L, Taboada P, Remuñán-López C, Almeida AJ. 2017. Microencapsulated SLN: an innovative strategy for pulmonary protein delivery. Int J Pharm. 516:231–246.
   PubMedGoogle Scholar
• Jafarinejad S, Gilani K, Moazeni E, Ghazi-Khansari M, Najafabadi AR, Mohajel N. 2012. Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation. Powder Technol. 222:65–70.
   Web of Science ®Google Scholar
• Jain D, Banerjee R. 2008. Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res. 86:105–112.
   Web of Science ®Google Scholar
• Kalia S, Sabaa M. 2013. Polysaccharide based graft copolymers. Berlin Heidelberg: Springer.
   Google Scholar
• Khandouzi F, Daman Z, Gilani K. 2017. Optimized particle engineering of fluticasone propionate and salmeterol xinafoate by spray drying technique for dry powder inhalation. Adv Powder Technol. 28:534–542.
   Web of Science ®Google Scholar
• Lebhardt T, Roesler S, Uusitalo HP, Kissel T. 2011. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation. Eur J Pharm Biopharm. 78:90–96.
   PubMed Web of Science ®Google Scholar
• Li HY, Seville PC, Williamson I, Birchall J. 2005. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J Gene Med. 7:343–353.
   PubMed Web of Science ®Google Scholar
• Li Y-Z, Sun X, Gong T, Liu J, Zuo J, Zhang Z-R. 2010. Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles. Pharm Res. 27:1977–1986.
   PubMed Web of Science ®Google Scholar
• Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, Fazeli MR, Jamalifar H. 2010. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul. 27:618–627.
   PubMed Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B, Watts J. 2011. Clarke’s analysis of drugs and poisons: in Pharmaceuticals, body fluids and postmortem material. Vol. 2. Chicago, IL: Pharmaceutical Press.
   Google Scholar
• Moghaddam PH, Ramezani V, Esfandi E, Vatanara A, Nabi-Meibodi M, Darabi M, Gilani K, Najafabadi A. 2013. Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin. Powder Technol. 239:478–483.
   Web of Science ®Google Scholar
• Ocaña J, Frutos G, Sánchez P. 2009. Using the similarity factor f2 in practice: a critical revision and suggestions for its standard error estimation. Chemome Intell Lab Syst. 99:49–56.
   Web of Science ®Google Scholar
• Ong HX, Traini D, Bebawy M, Young PM. 2013. Ciprofloxacin is actively transported across bronchial lung epithelial cells using a calu-3 air interface cell model. Antimicrob Agents Chemother. 57:2535–2540.
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. 2010. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 392:1–19.
   PubMed Web of Science ®Google Scholar
• Pourshahab PS, Gilani K, Moazeni E, Eslahi H, Fazeli MR, Jamalifar H. 2011. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid. J Microencapsul. 28:605–613.
   PubMed Web of Science ®Google Scholar
• RoSièRe R, Gelbcke M, Mathieu V, Van Antwerpen P, Amighi K, Wauthoz N. 2015. New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy. Int J Oncol. 47:1131–1142.
   PubMed Web of Science ®Google Scholar
• Sinsuebpol C, Chatchawalsaisin J, Kulvanich P. 2013. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Drug Des Dev Ther. 7:861
   PubMed Web of Science ®Google Scholar
• Stass H, Nagelschmitz J, Willmann S, Delesen H, Gupta A, Baumann S. 2013. Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study. Clin Drug Invest. 33:419–427.
   PubMed Web of Science ®Google Scholar
• Tewa-Tagne P, Briançon S, Fessi H. 2007. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. Eur J Pharm Sci. 30:124–135.
   PubMed Web of Science ®Google Scholar
• Vadakkan MV, Annapoorna K, Sivakumar K, Mundayoor S, Kumar GV. 2013. Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage. Int J Nanomed. 8:2871.
   PubMedGoogle Scholar
• Varshosaz J, Taymouri S, Hamishehkar H, Vatankhah R, Yaghubi S. 2017. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles. Res Pharm Sci. 12:222.
   PubMed Web of Science ®Google Scholar
• Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X. 2009. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 376:176–185.
   PubMed Web of Science ®Google Scholar
• Yang Y-T, Chen C-T, Yang J-C, Tsai T. 2010. Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin. Am Assoc Pharm Sci J. 12:138–146.
   Google Scholar